PHGE Insider Trading

Insider Ownership Percentage: 21.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,900,000.00

BiomX Insider Trading History Chart

This chart shows the insider buying and selling history at BiomX by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BiomX Share Price & Price History

Current Price: $5.04
Price Change: Price Decrease of -0.19 (-3.63%)
As of 03/18/2026 05:10 PM ET

This chart shows the closing price history over time for PHGE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BiomX Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2026Reuven YeganehDirectorSell530,000$5.00$2,650,000.00View SEC Filing Icon  
3/16/2026Reuven YeganehDirectorSell450,000$5.00$2,250,000.00View SEC Filing Icon  
5/15/2024Israel Biofund Gp Limi OrbimedMajor ShareholderSell128$72.20$9,241.6072,492View SEC Filing Icon  
11/29/2023Assaf OroninsiderSell574$7.03$4,035.22View SEC Filing Icon  
5/22/2023Assaf OronInsiderBuy16$51.30$820.8057View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BiomX (NYSEAMERICAN:PHGE)

40.57% of BiomX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PHGE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BiomX Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC19,473$36K0.0%-95.0%1.225%Search for SEC Filing on Google Icon
2/13/2026Nantahala Capital Management LLC114,795$0.22M0.0%-95.4%7.220%Search for SEC Filing on Google Icon
11/17/2025Alyeska Investment Group L.P.1,590,738$0.84M0.0%N/A5.990%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC161,781$85K0.0%N/A0.609%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC104,463$55K0.0%-56.0%0.393%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC77,656$41K0.0%-74.1%0.292%Search for SEC Filing on Google Icon
8/12/2025Warberg Asset Management LLC80,000$36K0.0%-19.7%0.306%Search for SEC Filing on Google Icon
5/16/2025Allostery Investments LP940,629$0.52M0.8%+46.1%3.763%Search for SEC Filing on Google Icon
5/16/2025Alyeska Investment Group L.P.1,590,738$0.88M0.0%+83.8%6.364%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC299,598$0.17M0.0%N/A1.199%Search for SEC Filing on Google Icon
5/15/2025Nantahala Capital Management LLC2,493,309$1.39M0.1%+44.1%9.975%Search for SEC Filing on Google Icon
5/9/2025Warberg Asset Management LLC99,616$55K0.0%N/A0.399%Search for SEC Filing on Google Icon
5/6/2025AIGH Capital Management LLC1,566,944$0.87M0.4%+81.1%6.269%Search for SEC Filing on Google Icon
2/17/2025Alyeska Investment Group L.P.865,400$0.63M0.0%N/A4.761%Search for SEC Filing on Google Icon
2/17/2025Allostery Investments LP643,833$0.47M0.5%N/A3.542%Search for SEC Filing on Google Icon
2/14/2025Heights Capital Management Inc.258,492$0.19M0.1%-56.1%1.422%Search for SEC Filing on Google Icon
2/14/2025Johnson & Johnson96,866$71K0.0%-49.6%0.533%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.429,990$0.31M0.0%N/A2.366%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC25,000$26K0.0%-90.0%0.138%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC25,000$26K0.0%-90.0%0.140%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC893,000$0.91M0.1%N/A4.990%Search for SEC Filing on Google Icon
11/14/2024Johnson & Johnson192,321$0.20M0.0%-90.0%1.075%Search for SEC Filing on Google Icon
11/7/20248VC GP I LLC108,621$0.11M0.2%-90.0%0.607%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC10,817,327$4.87M0.5%N/A19.590%Search for SEC Filing on Google Icon
5/10/2024Johnson & Johnson1,923,201$0.87M0.0%-9.9%3.483%Search for SEC Filing on Google Icon
2/12/2024MMCAP International Inc. SPC96,805$26K0.0%-81.1%0.211%Search for SEC Filing on Google Icon
2/12/20248VC GP I LLC1,086,191$0.30M0.3%N/A2.362%Search for SEC Filing on Google Icon
11/3/2022Royce & Associates LP158,655$54K0.0%-51.7%0.529%Search for SEC Filing on Google Icon
5/5/2022Royce & Associates LP320,655$0.62M0.0%+200.5%1.077%Search for SEC Filing on Google Icon
2/7/2022Royce & Associates LP106,696$0.17M0.0%-52.7%0.373%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BiomX logo
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Read More on BiomX

Today's Range

Now: $5.04
Low: $4.80
High: $5.23

50 Day Range

MA: $4.92
Low: $2.24
High: $7.50

52 Week Range

Now: $5.04
Low: $1.50
High: $14.71

Volume

52,934 shs

Average Volume

76,315 shs

Market Capitalization

$8.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Who are the company insiders with the largest holdings of BiomX?

BiomX's top insider investors include:
  1. Israel Biofund Gp Limi Orbimed (Major Shareholder)
  2. Reuven Yeganeh (Director)
Learn More about top insider investors at BiomX.

Who are the major institutional investors of BiomX?

BiomX's top institutional investors include:
  1. Nantahala Capital Management LLC — 7.22%
  2. Ikarian Capital LLC — 1.22%
Learn More about top institutional investors of BiomX stock.

Which institutional investors are selling BiomX stock?

In the previous quarter, PHGE stock was sold by these institutional investors:
  1. Nantahala Capital Management LLC
  2. Ikarian Capital LLC